Pseudomonas Aeruginosa and Cystic Fibrosis: Antibiotic Therapy and the Science behind the Magic
Respiratory failure secondary to chronic bronchiectasis is the cause of death in more than 90% of patients with cystic fibrosis (CF). The predominant microbes involved in CF lung disease are unusual: Pseudomonas aeruginosa, Staphylococcus aureus and Burkolderia cepacia. While antimicrobial therapy h...
Saved in:
Main Author: | Noni E MacDonald |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1997-01-01
|
Series: | Canadian Journal of Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/1997/617690 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted Antibiotic Prophylaxis for Lung Transplantation in Cystic Fibrosis Patients Colonised with Pseudomonas aeruginosa Using Multiple Combination Bactericidal Testing
by: Helmy Haja Mydin, et al.
Published: (2012-01-01) -
Pseudomonas cepacia in cystic fibrosis
by: Ronald Gold
Published: (1993-01-01) -
Comparative Efficacy of Two Doses of Nebulized Colistimethate for the Eradication of Pseudomonas Aeruginosa in Children with Cystic Fibrosis
by: Marie-Sophie Brochet, et al.
Published: (2007-01-01) -
Epidemiology of Pseudomonas cepacia in Cystic Fibrosis
by: Statement from the Medical/Scientific Advisory Committee Canadian Cystic Fibrosis Foundation
Published: (1993-01-01) -
Evidence for the Involvement of Lipid Rafts and Plasma Membrane Sphingolipid Hydrolases in Pseudomonas aeruginosa Infection of Cystic Fibrosis Bronchial Epithelial Cells
by: Domitilla Schiumarini, et al.
Published: (2017-01-01)